The Baruch S. Blumberg Institute, presented the 2024 Lam Excellence in Medicinal Chemistry Award recently to Marianne Carlsen, senior scientist at Fox Chase Therapeutics Discovery, Inc. (FCTDI), located in Doylestown.
(L-R) Dr. Ju-Tao Guo; Blumberg Institute; Dr. Allen Reitz, FCTDI; Dr. Patrick Y. S. Lam; Marianne Carlsen, FCTDI; Dr. Yanming Du, Blumberg Institute; and Dr. Jason Clement, Blumberg Institute
Marianne has been on the FCTDI team since January of 2018 working as a dedicated scientist with a strong background in pharmaceutical and agricultural R&D in both Europe and the U.S. She has more than 12 years’ experience in drug discovery immunology in a variety of target areas.
The Blumberg Institute presents the Lam Excellence in Medicinal Chemistry Award annually in recognition of Patrick Y. S. Lam, PhD, distinguished professor at the Blumberg Institute. Dr. Lam has established a strong model for medicinal chemists that embodies two essential areas. First, as co-inventor of Eliquis, a novel transformative anticoagulant that helps to alleviate human suffering. Second, as co-inventor of the powerful Chan-Lam Coupling Reaction used in synthesizing/manufacturing of biologically-active compounds.
The Lam Award was created in 2021 by Yanming Du, PhD, professor and director of medicinal chemistry at the Blumberg Institute.
About the Baruch S. Blumberg Institute: An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is a leading center for translational research in hepatitis B, liver cancer and related diseases. The Blumberg Institute manages the Pennsylvania Biotechnology Center (PABC) in Doylestown, where it is located, and B+labs at Cira Centre in Philadelphia. Visit our website and follow us on LinkedIn and X, @BlumbergInstit1.
The Baruch S. Blumberg Institute, presented the 2024 Lam Excellence in Medicinal Chemistry Award recently to Marianne Carlsen, senior scientist at Fox Chase Therapeutics Discovery, Inc. (FCTDI), located in Doylestown.
(L-R) Dr. Ju-Tao Guo; Blumberg Institute; Dr. Allen Reitz, FCTDI; Dr. Patrick Y. S. Lam; Marianne Carlsen, FCTDI; Dr. Yanming Du, Blumberg Institute; and Dr. Jason Clement, Blumberg Institute
Marianne has been on the FCTDI team since January of 2018 working as a dedicated scientist with a strong background in pharmaceutical and agricultural R&D in both Europe and the U.S. She has more than 12 years’ experience in drug discovery immunology in a variety of target areas.
The Blumberg Institute presents the Lam Excellence in Medicinal Chemistry Award annually in recognition of Patrick Y. S. Lam, PhD, distinguished professor at the Blumberg Institute. Dr. Lam has established a strong model for medicinal chemists that embodies two essential areas. First, as co-inventor of Eliquis, a novel transformative anticoagulant that helps to alleviate human suffering. Second, as co-inventor of the powerful Chan-Lam Coupling Reaction used in synthesizing/manufacturing of biologically-active compounds.
The Lam Award was created in 2021 by Yanming Du, PhD, professor and director of medicinal chemistry at the Blumberg Institute.
About the Baruch S. Blumberg Institute: An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is a leading center for translational research in hepatitis B, liver cancer and related diseases. The Blumberg Institute manages the Pennsylvania Biotechnology Center (PABC) in Doylestown, where it is located, and B+labs at Cira Centre in Philadelphia. Visit our website and follow us on LinkedIn and X, @BlumbergInstit1.